Evidence map›Paper›PMID 31506315›Full record

ArticlemBio2019

Antibiotics: Combatting Tolerance To Stop Resistance.

Etthel M Windels, Joran E Michiels, Bram Van den Bergh, Maarten Fauvart, Jan Michiels

Abstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. First Report ofAntibiotics (Basel, Switzerland) · 2025
    Article
  13. Review
  14. Eradication ofACS infectious diseases · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Etthel M Windels *VIB Center for Microbiology, Flanders Institute for Biotechnology, Leuven, Belgium.
Joran E Michiels *VIB Center for Microbiology, Flanders Institute for Biotechnology, Leuven, Belgium.
Bram Van den BerghVIB Center for Microbiology, Flanders Institute for Biotechnology, Leuven, Belgium.
Maarten FauvartVIB Center for Microbiology, Flanders Institute for Biotechnology, Leuven, Belgium.
Jan MichielsVIB Center for Microbiology, Flanders Institute for Biotechnology, Leuven, Belgium jan.michiels@kuleuven.vib.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance poses an alarming and ever-increasing threat to modern health care. Although the current antibiotic crisis is widely acknowledged, actions taken so far have proved insufficient to slow down the rampant spread of resistant pathogens. Problematically, routine screening methods and strategies to restrict therapy failure almost exclusively focus on genetic resistance, while evidence for dangers posed by other bacterial survival strategies is mounting. Antibiotic tolerance, occurring either population-wide or in a subpopulation of cells, allows bacteria to transiently overcome antibiotic treatment and is overlooked in clinical practice. In addition to prolonging treatment and causing relapsing infections, recent studies have revealed that tolerance also accelerates the emergence of resistance. These critical findings emphasize the need for strategies to combat tolerance, not only to improve treatment of recurrent infections but also to effectively address the problem of antibiotic resistance at the root.

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsBacterial Physiological PhenomenaDrug Resistance, BacterialDrug ToleranceEvolution, MolecularHumansAnti-Bacterial Agentsantibiotic resistanceantibioticsevolutionpersistence

Identifiers

PMID31506315
PMCPMC6737247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.